
NEA (New Enterprise Associates) is a global venture capital firm founded in 1977, investing in technology and healthcare companies across all stages from seed through IPO. In January 2023, the firm closed its latest funds totaling approximately $6.2 billion, comprising NEA 18 ($3.05B for early-stage) and NEA 18 Venture Growth Equity ($3.18B for growth-stage).
Deal activity decreased year-over-year (32 deals in the last 12 months vs 46 prior). Average disclosed round size is $89.8M (across 945 rounds with reported amounts).
Portfolio
582
Fund Size
$6.2B
Top Stage
Series B
Last 12 Mo
32
Team
Ali Behbahani, MD
Partner, Co-Head of Healthcare
Edward Mathers
Partner
Forest Baskett, PhD
Special Partner
Looking for someone who isn't listed here?
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round |
|---|---|
| Series E | |
| PP-1 AIJul 2026 · $50M | Series A |
| Series B | |
| Series D | |
| Series A | |
| Series A | |
| Seed | |
| Series A | |
| Series A | |
| Series B | |
| Series B | |
| Series C | |
| Series B | |
| Series D | |
| RRecludix PharmaJan 2026 | Series B |
| Series A | |
| Series D | |
| Series A | |
| Seed | |
| TThemis Solutions Inc.Jan 2026 · $500M | Growth |
| BBluefish LabsJan 2026 · $43M | Series B |
| SSingularityJan 2026 · $80M | Series A |
| Seed | |
| Series D | |
| Series A |
Looking for the people behind these companies?
Top Co-Investors
Last updated: 18 November 2026